BOSTON (GenomeWeb News) – A targeted gene panel developed by University of Washington researchers found that some women, who had a family history of breast and ovarian cancer, and who had received negative test results from Myriad Genetics' BRACAnalysis test, in fact, had BRCA1 and BRCA2 mutations that BRACAnalysis did not pick up.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.